These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 939474)

  • 1. Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop.
    Radó JP; Sawinsky I; Juhos E
    Horm Metab Res; 1976 May; 8(3):250-1. PubMed ID: 939474
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
    Radó JP; Sawinsky I; Juhos E
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):163-7. PubMed ID: 1002353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S; Reynolds TB
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract]   [Full Text] [Related]  

  • 4. Maintenance of potassium balance during diuretic therapy.
    Kohvakka A; Eisalo A; Manninen V
    Acta Med Scand; 1979; 205(4):319-24. PubMed ID: 373393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacology of potassium-sparing diuretics: amiloride and triamterene].
    Rorive G; Bovy P
    Coeur Med Interne; 1978; 17(2):207-15. PubMed ID: 350481
    [No Abstract]   [Full Text] [Related]  

  • 6. [Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].
    Haris A; Radó J
    Orv Hetil; 1996 Sep; 137(35):1907-14. PubMed ID: 8927344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Letter: Potassium retaining diuretics].
    Brummer P
    Duodecim; 1974; 90(23):1691-4. PubMed ID: 4459073
    [No Abstract]   [Full Text] [Related]  

  • 8. Potassium metabolism and diuretics administration in liver cirrhosis.
    Vesin P
    Postgrad Med J; 1975 Aug; 51(598):545-8. PubMed ID: 1234339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The physiopathologic basis and limitations of treatment of cirrhotic edema with diuretics retaining potassium.
    Vesin P
    Mater Med Pol; 1974; 6(3):199-201. PubMed ID: 4444335
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P
    Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
    [No Abstract]   [Full Text] [Related]  

  • 11. Opposite effects of spironolactone and amiloride on potassium excretion in a patient with ascites due to liver cirrhosis.
    Radó JP; Juhos E
    Endokrinologie; 1976 Jul; 67(3):377-9. PubMed ID: 976213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme).
    Macfie HL; Colvin CL; Anderson PO
    Drug Intell Clin Pharm; 1981 Feb; 15(2):94-8. PubMed ID: 7274028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spirolactones and potassium-sparing diuretics].
    Thibonnier M; Corvol P; Milliez P
    Rev Prat; 1978 Nov; 28(51):4021-4, 4027-8, 4031-2. PubMed ID: 741188
    [No Abstract]   [Full Text] [Related]  

  • 14. Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy.
    Andriulli A; Arrigoni A; Gindro T; Karbowiak I; Buzzetti G; Armanini D
    Digestion; 1989; 44(3):155-62. PubMed ID: 2697627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of amiloride, a potassium-sparing diuretic.
    Lant AF; Smith AJ; Wilson GM
    Clin Pharmacol Ther; 1969; 10(1):50-63. PubMed ID: 4884296
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of hypokalaemia due to diuretics.
    Leemhuis MP; Struyvenberg A
    Neth J Med; 1973; 16(1):18-28. PubMed ID: 4572424
    [No Abstract]   [Full Text] [Related]  

  • 17. Potassium-sparing diuretics: spironolactone v. triamterene and amiloride.
    Drug Ther Bull; 1972 Apr; 10(8):30-2. PubMed ID: 5038791
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical use of the potassium-sparing diuretics.
    Krishna GG; Shulman MD; Narins RG
    Semin Nephrol; 1988 Dec; 8(4):354-64. PubMed ID: 3068756
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
    Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
    Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M; Duhalt R; Peña JC
    Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.